Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Sophisticated Sequencing Techniques Used to Study Ancient Humans

By LabMedica International staff writers
Posted on 20 Jan 2010
DNA that is left in the remains of long-dead plants, animals, or humans allows a direct look into the history of evolution. More...
Up to now, studies of this sort on ancestral members of the human species have been hindered by scientists' inability to differentiate the ancient DNA from modern-day human DNA contamination. Now, new research overcomes this hurdle and shows how it is possible to directly analyze DNA from a member of our own species who lived around 30,000 years ago.

DNA is a robust molecule and can persist, conditions permitting, for several tens of thousands of years. Such ancient DNA provides scientists with unique possibilities to directly see into the genetic composition of organisms that have long since vanished from the Earth. Using ancient DNA extracted from bones, the biology of extinct animals as well as of ancient humans, such as the Neanderthals, has been successfully studied in recent years.

This ancient DNA application could not be easily applied to ancient members of the human species. This is because the ancient DNA fragments are multiplied with customized molecular probes that target specific DNA sequences. These probes, however, cannot distinguish whether the DNA they recognize comes from the ancient human sample or was introduced much later, for instance, by the archaeologists who handled the bones. Therefore, conclusions about the genetic make-up of ancient humans were filled with uncertainty.

Using the remains of humans that lived in Russia approximately 30,000 years ago, research by Dr. Svante Pääbo and his colleagues from the Max-Planck Institute for Evolutionary Anthropology (Leipzig, Germany) and published online on December 31, 2009, in the journal Current Biology, now make use of the latest DNA sequencing techniques to overcome this problem. These techniques, known as "second-generation sequencing,” enable the researchers to "read” directly from ancient DNA molecules, without having to use probes to multiply the DNA. Moreover, they can read from very short sequence fragments that are typical of DNA ancient remains because over time the DNA strands tend to degrade.

By contrast, DNA that is younger and only recently encountered the sample would consist of much longer fragments. This and other characteristics, such as the chemical damage incurred by ancient as opposed to modern DNA, effectively enabled the researchers to differentiate between genuine ancient DNA molecules and modern contamination. "We can now do what I thought was impossible just a year ago-- determine reliable DNA sequences from modern humans--but this is still possible only from very well preserved specimens,” stated Dr. Pääbo.

The application of this technology to the remains of members of the human species that lived tens of thousands of years ago now opens a possibility to address questions about the evolution and prehistory of ancient humans that were not possible with previous methods; for instance, whether the humans living in Europe 30,000 years ago are the direct ancestors of present-day Europeans or whether they were later replaced by immigrants that brought new technology such as agriculture with them.

Related Links:

Max-Planck Institute for Evolutionary Anthropology




Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.